Ganoderma triterpenoids attenuate tumour angiogenesis in lung cancer tumour-bearing nude mice.
CONCLUSIONS: Our study provided evidence that GLT and GEF combination therapy may be a promising candidate for the treatment of lung cancer and as an experimental basis for clinical treatment.
PMID: 33161828 [PubMed - in process]
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Tags: Pharm Biol Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Drugs & Pharmacology | Ganoderma | Lung Cancer | Study